| Symbol |
Name |
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACE2
|
angiotensin I converting enzyme 2
|
|
ADAM19
|
ADAM metallopeptidase domain 19
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADM
|
adrenomedullin
|
|
AFP
|
alpha-fetoprotein
|
|
AICDA
|
activation-induced cytidine deaminase
|
|
AIRE
|
autoimmune regulator
|
|
AKR1C1
|
aldo-keto reductase family 1, member C1
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
AMACR
|
alpha-methylacyl-CoA racemase
|
|
AMPD1
|
adenosine monophosphate deaminase 1
|
|
AMPD2
|
adenosine monophosphate deaminase 2
|
|
AMPD3
|
adenosine monophosphate deaminase 3
|
|
ANPEP
|
alanyl (membrane) aminopeptidase
|
|
APC
|
adenomatous polyposis coli
|
|
AQP1
|
aquaporin 1 (Colton blood group)
|
|
AQP3
|
aquaporin 3 (Gill blood group)
|
|
AQP4
|
aquaporin 4
|
|
AQP8
|
aquaporin 8
|
|
ARL6IP5
|
ADP-ribosylation factor-like 6 interacting protein 5
|
|
ASAH1
|
N-acylsphingosine amidohydrolase (acid ceramidase) 1
|
|
ASCL1
|
achaete-scute family bHLH transcription factor 1
|
|
AURKA
|
aurora kinase A
|
|
AXL
|
AXL receptor tyrosine kinase
|
|
B2M
|
beta-2-microglobulin
|
|
B3GAT1
|
beta-1,3-glucuronyltransferase 1
|
|
BAG1
|
BCL2-associated athanogene
|
|
BAG3
|
BCL2-associated athanogene 3
|
|
BBC3
|
BCL2 binding component 3
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BCR
|
breakpoint cluster region
|
|
BGLAP
|
bone gamma-carboxyglutamate (gla) protein
|
|
BHLHE40
|
basic helix-loop-helix family, member e40
|
|
BIN1
|
bridging integrator 1
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BMP2
|
bone morphogenetic protein 2
|
|
BMP5
|
bone morphogenetic protein 5
|
|
BMP7
|
bone morphogenetic protein 7
|
|
BNIP3
|
BCL2/adenovirus E1B 19kDa interacting protein 3
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BTRC
|
beta-transducin repeat containing E3 ubiquitin protein ligase
|
|
BUB1
|
BUB1 mitotic checkpoint serine/threonine kinase
|
|
CA1
|
carbonic anhydrase I
|
|
CA13
|
carbonic anhydrase XIII
|
|
CA2
|
carbonic anhydrase II
|
|
CALCA
|
calcitonin-related polypeptide alpha
|
|
CALR
|
calreticulin
|
|
CASP14
|
caspase 14, apoptosis-related cysteine peptidase
|
|
CASR
|
calcium-sensing receptor
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CCDC6
|
coiled-coil domain containing 6
|
|
CCL17
|
chemokine (C-C motif) ligand 17
|
|
CCL22
|
chemokine (C-C motif) ligand 22
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCND1
|
cyclin D1
|
|
CCND2
|
cyclin D2
|
|
CCND3
|
cyclin D3
|
|
CCNE1
|
cyclin E1
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
|
CD151
|
CD151 molecule (Raph blood group)
|
|
CD2
|
CD2 molecule
|
|
CD27
|
CD27 molecule
|
|
CD274
|
CD274 molecule
|
|
CD38
|
CD38 molecule
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
|
CD40LG
|
CD40 ligand
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CDC25C
|
cell division cycle 25C
|
|
CDC42
|
cell division cycle 42
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH13
|
cadherin 13
|
|
CDH2
|
cadherin 2, type 1, N-cadherin (neuronal)
|
|
CDH3
|
cadherin 3, type 1, P-cadherin (placental)
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDX2
|
caudal type homeobox 2
|
|
CEACAM1
|
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)
|
|
CEACAM5
|
carcinoembryonic antigen-related cell adhesion molecule 5
|
|
CEBPD
|
CCAAT/enhancer binding protein (C/EBP), delta
|
|
CEMIP
|
cell migration inducing protein, hyaluronan binding
|
|
CETP
|
cholesteryl ester transfer protein, plasma
|
|
CFL1
|
cofilin 1 (non-muscle)
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
|
CHFR
|
checkpoint with forkhead and ring finger domains, E3 ubiquitin protein ligase
|
|
CHGA
|
chromogranin A
|
|
CHGB
|
chromogranin B
|
|
CKS1B
|
CDC28 protein kinase regulatory subunit 1B
|
|
CKS2
|
CDC28 protein kinase regulatory subunit 2
|
|
CLDN1
|
claudin 1
|
|
CLDN4
|
claudin 4
|
|
CLU
|
clusterin
|
|
CRNN
|
cornulin
|
|
CRTC2
|
CREB regulated transcription coactivator 2
|
|
CSF1R
|
colony stimulating factor 1 receptor
|
|
CSPG4
|
chondroitin sulfate proteoglycan 4
|
|
CTH
|
cystathionine gamma-lyase
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTNNBIP1
|
catenin, beta interacting protein 1
|
|
CUL4A
|
cullin 4A
|
|
CUL4B
|
cullin 4B
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL13
|
chemokine (C-X-C motif) ligand 13
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYP26A1
|
cytochrome P450, family 26, subfamily A, polypeptide 1
|
|
CYP2A13
|
cytochrome P450, family 2, subfamily A, polypeptide 13
|
|
CYP2C8
|
cytochrome P450, family 2, subfamily C, polypeptide 8
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
CYP2J2
|
cytochrome P450, family 2, subfamily J, polypeptide 2
|
|
DAPK1
|
death-associated protein kinase 1
|
|
DDX3X
|
DEAD (Asp-Glu-Ala-Asp) box helicase 3, X-linked
|
|
DDX53
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 53
|
|
DIO3
|
deiodinase, iodothyronine, type III
|
|
DLX4
|
distal-less homeobox 4
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
|
DNMT3B
|
DNA (cytosine-5-)-methyltransferase 3 beta
|
|
DPEP1
|
dipeptidase 1 (renal)
|
|
DPP4
|
dipeptidyl-peptidase 4
|
|
DUSP6
|
dual specificity phosphatase 6
|
|
EBAG9
|
estrogen receptor binding site associated, antigen, 9
|
|
ECT2
|
epithelial cell transforming 2
|
|
EEF1A1
|
eukaryotic translation elongation factor 1 alpha 1
|
|
EEF1A2
|
eukaryotic translation elongation factor 1 alpha 2
|
|
EGFR
|
epidermal growth factor receptor
|
|
EIF2S1
|
eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa
|
|
EIF4A2
|
eukaryotic translation initiation factor 4A2
|
|
EIF4B
|
eukaryotic translation initiation factor 4B
|
|
EIF4E
|
eukaryotic translation initiation factor 4E
|
|
EIF4EBP1
|
eukaryotic translation initiation factor 4E binding protein 1
|
|
EIF4G1
|
eukaryotic translation initiation factor 4 gamma, 1
|
|
ELK3
|
ELK3, ETS-domain protein (SRF accessory protein 2)
|
|
EN1
|
engrailed homeobox 1
|
|
ENPEP
|
glutamyl aminopeptidase (aminopeptidase A)
|
|
ENPP3
|
ectonucleotide pyrophosphatase/phosphodiesterase 3
|
|
EPAS1
|
endothelial PAS domain protein 1
|
|
EPB41L3
|
erythrocyte membrane protein band 4.1-like 3
|
|
EPHA2
|
EPH receptor A2
|
|
EPHA3
|
EPH receptor A3
|
|
EPHA7
|
EPH receptor A7
|
|
EPHB1
|
EPH receptor B1
|
|
EPHX2
|
epoxide hydrolase 2, cytoplasmic
|
|
EPO
|
erythropoietin
|
|
EPOR
|
erythropoietin receptor
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ESRRA
|
estrogen-related receptor alpha
|
|
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
EZR
|
ezrin
|
|
FADD
|
Fas (TNFRSF6)-associated via death domain
|
|
FAP
|
fibroblast activation protein, alpha
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FBN1
|
fibrillin 1
|
|
FEV
|
FEV (ETS oncogene family)
|
|
FGF12
|
fibroblast growth factor 12
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FLI1
|
Fli-1 proto-oncogene, ETS transcription factor
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FLT4
|
fms-related tyrosine kinase 4
|
|
FN1
|
fibronectin 1
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FOXE1
|
forkhead box E1
|
|
FOXO1
|
forkhead box O1
|
|
FOXP3
|
forkhead box P3
|
|
FSHR
|
follicle stimulating hormone receptor
|
|
FUT4
|
fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific)
|
|
GAD2
|
glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa)
|
|
GALR1
|
galanin receptor 1
|
|
GAS6
|
growth arrest-specific 6
|
|
GATA1
|
GATA binding protein 1 (globin transcription factor 1)
|
|
GDF15
|
growth differentiation factor 15
|
|
GH1
|
growth hormone 1
|
|
GHR
|
growth hormone receptor
|
|
GKN1
|
gastrokine 1
|
|
GLP1R
|
glucagon-like peptide 1 receptor
|
|
GLS
|
glutaminase
|
|
GNA12
|
guanine nucleotide binding protein (G protein) alpha 12
|
|
GNL3
|
guanine nucleotide binding protein-like 3 (nucleolar)
|
|
GPER1
|
G protein-coupled estrogen receptor 1
|
|
GPI
|
glucose-6-phosphate isomerase
|
|
GPX1
|
glutathione peroxidase 1
|
|
GPX3
|
glutathione peroxidase 3
|
|
GREM1
|
gremlin 1, DAN family BMP antagonist
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
H19
|
H19, imprinted maternally expressed transcript (non-protein coding)
|
|
H2AFX
|
H2A histone family, member X
|
|
HDAC2
|
histone deacetylase 2
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
|
HLA-E
|
major histocompatibility complex, class I, E
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HLTF
|
helicase-like transcription factor
|
|
HMGA1
|
high mobility group AT-hook 1
|
|
HNF4A
|
hepatocyte nuclear factor 4, alpha
|
|
HOXB4
|
homeobox B4
|
|
HPSE2
|
heparanase 2 (inactive)
|
|
HSPB1
|
heat shock 27kDa protein 1
|
|
HSPD1
|
heat shock 60kDa protein 1 (chaperonin)
|
|
HTR2B
|
5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupled
|
|
HTR3A
|
5-hydroxytryptamine (serotonin) receptor 3A, ionotropic
|
|
ICOS
|
inducible T-cell co-stimulator
|
|
ID1
|
inhibitor of DNA binding 1, dominant negative helix-loop-helix protein
|
|
IDE
|
insulin-degrading enzyme
|
|
IFNG
|
interferon, gamma
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2BP3
|
insulin-like growth factor 2 mRNA binding protein 3
|
|
IL18
|
interleukin 18
|
|
IL1B
|
interleukin 1, beta
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL33
|
interleukin 33
|
|
IL6
|
interleukin 6
|
|
IL9
|
interleukin 9
|
|
ING1
|
inhibitor of growth family, member 1
|
|
INSL3
|
insulin-like 3 (Leydig cell)
|
|
IRF6
|
interferon regulatory factor 6
|
|
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit)
|
|
ITGAV
|
integrin, alpha V
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
ITGB4
|
integrin, beta 4
|
|
JAG1
|
jagged 1
|
|
JAK2
|
Janus kinase 2
|
|
JUN
|
jun proto-oncogene
|
|
KCNE1
|
potassium channel, voltage gated subfamily E regulatory beta subunit 1
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
|
KDR
|
kinase insert domain receptor
|
|
KIR3DL2
|
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2
|
|
KISS1
|
KiSS-1 metastasis-suppressor
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KITLG
|
KIT ligand
|
|
KMT2D
|
lysine (K)-specific methyltransferase 2D
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT13
|
keratin 13, type I
|
|
KRT14
|
keratin 14, type I
|
|
KRT17
|
keratin 17, type I
|
|
KRT19
|
keratin 19, type I
|
|
KRT20
|
keratin 20, type I
|
|
KRT7
|
keratin 7, type II
|
|
KRT8
|
keratin 8, type II
|
|
LAMB3
|
laminin, beta 3
|
|
LAMC2
|
laminin, gamma 2
|
|
LAT
|
linker for activation of T cells
|
|
LCN2
|
lipocalin 2
|
|
LEF1
|
lymphoid enhancer-binding factor 1
|
|
LETMD1
|
LETM1 domain containing 1
|
|
LGALS1
|
lectin, galactoside-binding, soluble, 1
|
|
LGALS7B
|
lectin, galactoside-binding, soluble, 7B
|
|
LGALS8
|
lectin, galactoside-binding, soluble, 8
|
|
LIN28B
|
lin-28 homolog B (C. elegans)
|
|
LNPEP
|
leucyl/cystinyl aminopeptidase
|
|
LTF
|
lactotransferrin
|
|
LTK
|
leukocyte receptor tyrosine kinase
|
|
MAD2L1
|
MAD2 mitotic arrest deficient-like 1 (yeast)
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAP2K2
|
mitogen-activated protein kinase kinase 2
|
|
MARVELD2
|
MARVEL domain containing 2
|
|
MC1R
|
melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor)
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MEN1
|
multiple endocrine neoplasia I
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
METAP2
|
methionyl aminopeptidase 2
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MIR152
|
microRNA 152
|
|
MIR155
|
microRNA 155
|
|
MIR223
|
microRNA 223
|
|
MIRLET7C
|
microRNA let-7c
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MME
|
membrane metallo-endopeptidase
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted)
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MPL
|
MPL proto-oncogene, thrombopoietin receptor
|
|
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1
|
|
MSH3
|
mutS homolog 3
|
|
MSI1
|
musashi RNA-binding protein 1
|
|
MSLN
|
mesothelin
|
|
MTBP
|
MDM2 binding protein
|
|
MTDH
|
metadherin
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUC17
|
mucin 17, cell surface associated
|
|
MUC2
|
mucin 2, oligomeric mucus/gel-forming
|
|
MUC3A
|
mucin 3A, cell surface associated
|
|
MUC5AC
|
mucin 5AC, oligomeric mucus/gel-forming
|
|
MUC6
|
mucin 6, oligomeric mucus/gel-forming
|
|
MUTYH
|
mutY homolog
|
|
MYBL2
|
v-myb avian myeloblastosis viral oncogene homolog-like 2
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYOD1
|
myogenic differentiation 1
|
|
NAPSA
|
napsin A aspartic peptidase
|
|
NELL1
|
NEL-like 1 (chicken)
|
|
NES
|
nestin
|
|
NF2
|
neurofibromin 2 (merlin)
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NGFR
|
nerve growth factor receptor
|
|
NME1
|
NME/NM23 nucleoside diphosphate kinase 1
|
|
NOTCH1
|
notch 1
|
|
NOTCH2
|
notch 2
|
|
NOX1
|
NADPH oxidase 1
|
|
NPR3
|
natriuretic peptide receptor 3
|
|
NR0B1
|
nuclear receptor subfamily 0, group B, member 1
|
|
NR1H4
|
nuclear receptor subfamily 1, group H, member 4
|
|
NRG1
|
neuregulin 1
|
|
NRP1
|
neuropilin 1
|
|
NRP2
|
neuropilin 2
|
|
NT5E
|
5'-nucleotidase, ecto (CD73)
|
|
NUCKS1
|
nuclear casein kinase and cyclin-dependent kinase substrate 1
|
|
NUP88
|
nucleoporin 88kDa
|
|
OCLN
|
occludin
|
|
PAM16
|
presequence translocase-associated motor 16 homolog (S. cerevisiae)
|
|
PARK7
|
parkinson protein 7
|
|
PAX5
|
paired box 5
|
|
PAX6
|
paired box 6
|
|
PBOV1
|
prostate and breast cancer overexpressed 1
|
|
PCNA
|
proliferating cell nuclear antigen
|
|
PCP4
|
Purkinje cell protein 4
|
|
PDCD1
|
programmed cell death 1
|
|
PDCD4
|
programmed cell death 4 (neoplastic transformation inhibitor)
|
|
PDGFA
|
platelet-derived growth factor alpha polypeptide
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PDPN
|
podoplanin
|
|
PEBP1
|
phosphatidylethanolamine binding protein 1
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
|
PER2
|
period circadian clock 2
|
|
PHOX2B
|
paired-like homeobox 2b
|
|
PKM
|
pyruvate kinase, muscle
|
|
PKP3
|
plakophilin 3
|
|
PLA2G10
|
phospholipase A2, group X
|
|
PLA2G2A
|
phospholipase A2, group IIA (platelets, synovial fluid)
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLCD1
|
phospholipase C, delta 1
|
|
PLCD3
|
phospholipase C, delta 3
|
|
PLK1
|
polo-like kinase 1
|
|
PLXNB1
|
plexin B1
|
|
PNOC
|
prepronociceptin
|
|
POMT1
|
protein-O-mannosyltransferase 1
|
|
PPP2R1A
|
protein phosphatase 2, regulatory subunit A, alpha
|
|
PRDM1
|
PR domain containing 1, with ZNF domain
|
|
PRKCB
|
protein kinase C, beta
|
|
PRKCD
|
protein kinase C, delta
|
|
PRL
|
prolactin
|
|
PRLR
|
prolactin receptor
|
|
PRMT5
|
protein arginine methyltransferase 5
|
|
PROM1
|
prominin 1
|
|
PROX1
|
prospero homeobox 1
|
|
PSCA
|
prostate stem cell antigen
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGER2
|
prostaglandin E receptor 2 (subtype EP2), 53kDa
|
|
PTGS1
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTHLH
|
parathyroid hormone-like hormone
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTPN23
|
protein tyrosine phosphatase, non-receptor type 23
|
|
PTPRJ
|
protein tyrosine phosphatase, receptor type, J
|
|
PTPRK
|
protein tyrosine phosphatase, receptor type, K
|
|
RABEP2
|
rabaptin, RAB GTPase binding effector protein 2
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RALBP1
|
ralA binding protein 1
|
|
RARRES1
|
retinoic acid receptor responder (tazarotene induced) 1
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RB1
|
retinoblastoma 1
|
|
RB1CC1
|
RB1-inducible coiled-coil 1
|
|
RCBTB2
|
regulator of chromosome condensation (RCC1) and BTB (POZ) domain containing protein 2
|
|
REG3A
|
regenerating islet-derived 3 alpha
|
|
REL
|
v-rel avian reticuloendotheliosis viral oncogene homolog
|
|
RET
|
ret proto-oncogene
|
|
RHOA
|
ras homolog family member A
|
|
RHOB
|
ras homolog family member B
|
|
RHOC
|
ras homolog family member C
|
|
RPL22
|
ribosomal protein L22
|
|
RPS6KA3
|
ribosomal protein S6 kinase, 90kDa, polypeptide 3
|
|
RSF1
|
remodeling and spacing factor 1
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RUNX2
|
runt-related transcription factor 2
|
|
RUNX3
|
runt-related transcription factor 3
|
|
RUVBL1
|
RuvB-like AAA ATPase 1
|
|
S100A12
|
S100 calcium binding protein A12
|
|
S100A6
|
S100 calcium binding protein A6
|
|
S100A9
|
S100 calcium binding protein A9
|
|
SAMD9
|
sterile alpha motif domain containing 9
|
|
SCD
|
stearoyl-CoA desaturase (delta-9-desaturase)
|
|
SCRIB
|
scribbled planar cell polarity protein
|
|
SDC1
|
syndecan 1
|
|
SELE
|
selectin E
|
|
SEMA3A
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A
|
|
SEPP1
|
selenoprotein P, plasma, 1
|
|
SERPINA9
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 9
|
|
SERPINB5
|
serpin peptidase inhibitor, clade B (ovalbumin), member 5
|
|
SFN
|
stratifin
|
|
SH2B1
|
SH2B adaptor protein 1
|
|
SLC16A1
|
solute carrier family 16 (monocarboxylate transporter), member 1
|
|
SLC1A2
|
solute carrier family 1 (glial high affinity glutamate transporter), member 2
|
|
SLC1A3
|
solute carrier family 1 (glial high affinity glutamate transporter), member 3
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SLC2A3
|
solute carrier family 2 (facilitated glucose transporter), member 3
|
|
SLC9A3R1
|
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 1
|
|
SMAD3
|
SMAD family member 3
|
|
SMAD4
|
SMAD family member 4
|
|
SMAD7
|
SMAD family member 7
|
|
SMARCB1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
|
|
SNAI2
|
snail family zinc finger 2
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SOX9
|
SRY (sex determining region Y)-box 9
|
|
SPINK1
|
serine peptidase inhibitor, Kazal type 1
|
|
SPN
|
sialophorin
|
|
SPRR3
|
small proline-rich protein 3
|
|
SRSF2
|
serine/arginine-rich splicing factor 2
|
|
SSTR1
|
somatostatin receptor 1
|
|
ST2
|
suppression of tumorigenicity 2
|
|
ST6GAL1
|
ST6 beta-galactosamide alpha-2,6-sialyltranferase 1
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STC1
|
stanniocalcin 1
|
|
STEAP1B
|
STEAP family member 1B
|
|
SYNE1
|
spectrin repeat containing, nuclear envelope 1
|
|
T
|
T, brachyury homolog (mouse)
|
|
TAC1
|
tachykinin, precursor 1
|
|
TAGLN
|
transgelin
|
|
TAGLN2
|
transgelin 2
|
|
TAPBP
|
TAP binding protein (tapasin)
|
|
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box)
|
|
TERT
|
telomerase reverse transcriptase
|
|
TFEB
|
transcription factor EB
|
|
TFF1
|
trefoil factor 1
|
|
TFF3
|
trefoil factor 3 (intestinal)
|
|
TFPI2
|
tissue factor pathway inhibitor 2
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
TGM2
|
transglutaminase 2
|
|
THOC1
|
THO complex 1
|
|
THPO
|
thrombopoietin
|
|
THRA
|
thyroid hormone receptor, alpha
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TIPE2
|
TNF alpha induced protein 8 like 2
|
|
TLR10
|
toll-like receptor 10
|
|
TLR4
|
toll-like receptor 4
|
|
TLR9
|
toll-like receptor 9
|
|
TNC
|
tenascin C
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF12A
|
tumor necrosis factor receptor superfamily, member 12A
|
|
TNFRSF8
|
tumor necrosis factor receptor superfamily, member 8
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF13
|
tumor necrosis factor (ligand) superfamily, member 13
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TP53
|
tumor protein p53
|
|
TP63
|
tumor protein p63
|
|
TRPC5
|
transient receptor potential cation channel, subfamily C, member 5
|
|
TSPY1
|
testis specific protein, Y-linked 1
|
|
TUBB3
|
tubulin, beta 3 class III
|
|
TWIST1
|
twist family bHLH transcription factor 1
|
|
TXNRD1
|
thioredoxin reductase 1
|
|
TYMS
|
thymidylate synthetase
|
|
U2AF1
|
U2 small nuclear RNA auxiliary factor 1
|
|
UBE2I
|
ubiquitin-conjugating enzyme E2I
|
|
UGT2B7
|
UDP glucuronosyltransferase 2 family, polypeptide B7
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VEGFC
|
vascular endothelial growth factor C
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
WDR19
|
WD repeat domain 19
|
|
WT1
|
Wilms tumor 1
|
|
WWOX
|
WW domain containing oxidoreductase
|
|
WWTR1
|
WW domain containing transcription regulator 1
|
|
XPC
|
xeroderma pigmentosum, complementation group C
|
|
YY1
|
YY1 transcription factor
|
|
ZBTB7B
|
zinc finger and BTB domain containing 7B
|
|
ZNF217
|
zinc finger protein 217
|
